English | Español

Eli Lilly And Company
Carol Ostrow | Oct 14, 2017

Lilly wins right to patent Alimta vitamin treatment for certain lung cancers
Carrie Bradon | Sep 21, 2017

Oncology Data Network called key to improving health care in Europe
Carol Ostrow | Sep 20, 2017

Lilly study supports Cyramza (ramucirumab) efficacy for treating urothelial carcinoma
Carrie Bradon | Jul 9, 2017

Japanese Ministry of Health, Labor and Welfare approves Olumiant
Erianne Leatherman | Jun 21, 2017

Lilly says its galcanezumab cuts down on amount of migraine headache days

Ruth de Jauregui | Jun 14, 2017

Boehringer Ingelheim, Eli Lilly to collaborate in trial of empagliflozin for chronic kidney disease
Robert Hadley | Jun 14, 2017

Eli Lilly anti-cancer drug may halt breast cancer spread when paired with fulvestrant
Ruth de Jauregui | May 21, 2017

Lilly says studies show galcanezumab can reduce migraine episodes

Trending
Patient Daily | Jul 8, 2025

Clinical assistant professor at Stanford: ‘Musical background is associated with better performance of fundamental surgical skills'
+ Pharmaceuticals
Patient Daily | Jul 10, 2025

PhRMA Executive VP: ‘State policymakers can lead the way and must address 340B abuse and protect patients from PBMs'
+ Pharmaceuticals
Patient Daily | Jul 8, 2025

Psychedelic mushrooms' compound shows potential antiaging effects
Patient Daily | Jul 9, 2025

FDA approves Longeveron's Phase 2 study for pediatric dilated cardiomyopathy treatment